Comments To CMS re Proposed Decision for Beta Amyloid PET Scan

Click here to view the comment from ResearchersAgainstAlzheimer’s, which was submitted to CMS on Friday, August 2. ResearchersAgainstAlzheimer’s requests that CMS reconsider and revise this proposed decision. Specifically, we request that CMS issue a National Coverage Determination for PET Aβ imaging for carefully defined patients with difficult-to-diagnose memory disorders, especially as described by the Appropriate Use Criteria (AUC) issued by the Amyloid Imaging Task Force (AIT).